UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended June 30, 2021 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission file number 000-31615 DURECT CORPORATION (Exact name of registrant as specified in its charter) Delaware 94-3297098 (State or other jurisdiction of incorpor ...

DURECT Corporation (NASDAQ:DRRX) Q1 2021 Earnings Conference Call May 4, 2021 4:30 PM ET Company Participants Mike Arenberg – Chief Financial Officer Jim Brown – President and Chief Executive Officer WeiQi Lin – Executive Vice President-Research and Development, Principal Scientist Norman Sussman – Chief Medical Officer Conference Call Participants Francois Brisebois – Oppenheimer Kristen Kluska – Cantor Fitzgerald Ed Arce – H.C. Wainwright Michael Morabito – Chardan Capital Markets Operator Greetings, and ...

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended March 31, 2021 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission file number 000-31615 DURECT CORPORATION (Exact name of registrant as specified in its charter) Delaware 94-3297098 (State or other jurisdiction of incorpo ...

DURECT Corporation (NASDAQ:DRRX) Q4 2020 Earnings Conference Call March 4, 2021 4:30 PM ET Company Participants Mike Arenberg - CFO Jim Brown - President & CEO WeiQi Lin - EVP, Research & Development & Principal Scientist Norman Sussman - Chief Medical Officer Conference Call Participants Francois Brisebois - Oppenheimer Kristen Kluska - Cantor Fitzgerald Sahil Kazmi - B. Riley Michael Morabito - Chardan Capital Markets Ed Arce - H.C. Wainwright Operator Greetings, and welcome to the DURECT Corporation Four ...

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 10-K (Mark One) ☒ ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended December 31, 2020 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission file number: 000-31615 DURECT CORPORATION (Exact name of registrant as specified in its charter) Delaware 94-3297098 (State or other jurisdiction of ...

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended September 30, 2020 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission file number 000-31615 DURECT CORPORATION (Exact name of registrant as specified in its charter) Delaware 94-3297098 (State or other jurisdiction of inc ...

DURECT Corporation (NASDAQ:DRRX) Q3 2020 Earnings Conference Call November 2, 2020 4:30 PM ET Company Participants Mike Arenberg - Chief Financial Officer Jim Brown - President & Chief Executive Officer WeiQi Lin - Executive Vice President, Research & Development & Principal Scientist Conference Call Participants Kristen Kluska - Cantor Fitzgerald Francois Brisebois - Oppenheimer Mayank Mamtani - B. Riley Michael Morabito - Chardan Capital Markets Thomas Yip - H.C. Wainwright Elemer Piros - ROTH Capital Par ...

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended June 30, 2020 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission file number 000-31615 DURECT CORPORATION (Exact name of registrant as specified in its charter) Delaware 94-3297098 (State or other jurisdiction of incorpor ...

DURECT Corporation (NASDAQ:DRRX) Q2 2020 Earnings Conference Call August 3, 2020 4:30 PM ET Company Participants Mike Arenberg - Chief Financial Officer Jim Brown - President & Chief Executive Officer WeiQi Lin - Executive Vice President, Research & Development & Principal Scientist Conference Call Participants Ellie Merle - Cantor Fitzgerald Mayank Mamtani - B. Riley Francois Brisebois - Oppenheimer Ed Arce - H.C. Wainwright Len Yaffe - Stocdoc Partners Operator Greetings and welcome to the DURECT Corporat ...

DURECT Corp (NASDAQ:DRRX) Q1 2020 Earnings Conference Call May 11, 2020 4:30 PM ET Company Participants Michael Arenberg - CFO & Secretary James Brown - Co-Founder, CEO, President & Director WeiQi Lin - EVP, Research & Development & Principal Scientist Conference Call Participants Antonio Arce - H.C. Wainwright & Co. François Brisebois - Craig-Hallum Len Yaffe - Stoc*Doc Partners Mayank Mamtani - B. Riley FBR, Inc. Operator Greetings, and welcome to the DURECT Corporation First Quarter 2020 Results Conferen ...